Search
for
Sort by
Research 31–60 of 552
- The effects of phosphodiesterase 3 (PDE3) inhibitor on hair follicle cell viability and hair growth
- 570 Targeting phosphodiesterase 8A (PDE8A) to boost adipogenesis and hair regeneration
- 467 Novel selective phosphodiesterase inhibitors promote the adipogenic function of dermal fibroblasts: Implication to treat hair loss
- PD59-09 PHOSPHODIESTERASE INHIBITORS COULD REVERSE THE PROLIFERATION OF BPH EPITHELIAL CELLS INDUCED BY CD8+ T CELLS IN LOW ANDROGEN CONDITION
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- Phosphodiesterase inhibitors used in androgenic alopecia as a possible risk factor for testicular tumor
- Investigation, treatment and monitoring of late‐onset hypogonadism in males: ISA, ISSAM, and EAU recommendations
- Alopecia areata
- Caffeine’s Mechanisms of Action and Its Cosmetic Use
- Adverse effects of common medications on male fertility
- INTERACTION OF α-MELANOCYTE-STIMULATING HORMONE, MELATONIN, CYCLIC AMP AND CYCLIC GMP IN THE CONTROL OF MELANOGENESIS IN HAIR FOLLICLE MELANOCYTES IN VITRO
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Risks and side effects in the medical management of benign prostatic hyperplasia
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Persistent Sexual Dysfunction with Finasteride 1 mg Taken for Hair Loss
- Monovalent antibody-conjugated lipid-polymer nanohybrids for active targeting to desmoglein 3 of keratinocytes to attenuate psoriasiform inflammation
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Role of caffeine in the management of androgenetic alopecia
- Apremilast is efficacious in refractory alopecia areata
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- The ‘bald’ phenotype (androgenetic alopecia) is caused by the high glycaemic, high cholesterol and low mineral ‘western diet’
- Therapeutic use of caffeine in dermatology: A literature review
- Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review
- Alopecia areata: from pathophysiology to therapeutic innovation
- Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature
- Wider clinical applications of fumaric acid esters: A useful option in psoriasis patients with multiple sclerosis
- Approaching Erectile Dysfunction in Dermatology Patients
- Tribuloside acts on the PDE/cAMP/PKA pathway to enhance melanogenesis, melanocyte dendricity and melanosome transport
- The urologic impact of long-term finasteride 1-mg use for androgenic alopecia: a matched-cohort database analysis